M&T Bank Corp Increases Stake in DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

M&T Bank Corp boosted its holdings in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY) by 5.6% during the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 39,079 shares of the medical instruments supplier’s stock after buying an additional 2,062 shares during the quarter. M&T Bank Corp’s holdings in DENTSPLY SIRONA were worth $1,058,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in XRAY. First Eagle Investment Management LLC raised its holdings in DENTSPLY SIRONA by 33.6% in the second quarter. First Eagle Investment Management LLC now owns 13,069,900 shares of the medical instruments supplier’s stock valued at $325,571,000 after acquiring an additional 3,283,965 shares in the last quarter. Nuance Investments LLC raised its holdings in shares of DENTSPLY SIRONA by 3.8% in the 2nd quarter. Nuance Investments LLC now owns 10,879,916 shares of the medical instruments supplier’s stock valued at $271,019,000 after purchasing an additional 402,329 shares in the last quarter. FMR LLC lifted its position in shares of DENTSPLY SIRONA by 5.1% during the 3rd quarter. FMR LLC now owns 9,056,774 shares of the medical instruments supplier’s stock worth $245,076,000 after purchasing an additional 436,031 shares during the last quarter. Cooke & Bieler LP grew its stake in shares of DENTSPLY SIRONA by 16.2% during the second quarter. Cooke & Bieler LP now owns 7,506,845 shares of the medical instruments supplier’s stock worth $186,996,000 after purchasing an additional 1,046,105 shares in the last quarter. Finally, Dimensional Fund Advisors LP increased its holdings in DENTSPLY SIRONA by 42.0% in the second quarter. Dimensional Fund Advisors LP now owns 4,420,445 shares of the medical instruments supplier’s stock valued at $110,118,000 after buying an additional 1,308,411 shares during the last quarter. Hedge funds and other institutional investors own 95.70% of the company’s stock.

Analyst Ratings Changes

Several research analysts have recently issued reports on XRAY shares. Leerink Partners cut DENTSPLY SIRONA from an “outperform” rating to a “market perform” rating in a research report on Thursday, November 7th. Leerink Partnrs downgraded DENTSPLY SIRONA from a “strong-buy” rating to a “hold” rating in a report on Thursday, November 7th. Barrington Research decreased their target price on shares of DENTSPLY SIRONA from $36.00 to $24.00 and set an “outperform” rating for the company in a research note on Friday, November 8th. Needham & Company LLC lowered their price objective on shares of DENTSPLY SIRONA from $34.00 to $29.00 and set a “buy” rating on the stock in a research report on Friday, October 25th. Finally, Robert W. Baird lowered their target price on shares of DENTSPLY SIRONA from $31.00 to $24.00 and set a “neutral” rating on the stock in a report on Friday, November 8th. Eight research analysts have rated the stock with a hold rating and four have given a buy rating to the company. According to MarketBeat, DENTSPLY SIRONA has an average rating of “Hold” and an average price target of $28.40.

DENTSPLY SIRONA Price Performance

Shares of NASDAQ:XRAY opened at $19.72 on Monday. The firm has a market capitalization of $3.92 billion, a price-to-earnings ratio of -9.53, a price-to-earnings-growth ratio of 1.93 and a beta of 0.96. The company has a debt-to-equity ratio of 0.72, a current ratio of 1.25 and a quick ratio of 0.84. The business’s 50 day simple moving average is $21.28 and its 200-day simple moving average is $24.16. DENTSPLY SIRONA Inc. has a 12 month low of $17.21 and a 12 month high of $37.60.

DENTSPLY SIRONA (NASDAQ:XRAY) last posted its earnings results on Thursday, November 7th. The medical instruments supplier reported $0.50 earnings per share for the quarter, beating the consensus estimate of $0.48 by $0.02. The company had revenue of $951.00 million for the quarter, compared to analyst estimates of $939.10 million. DENTSPLY SIRONA had a positive return on equity of 12.62% and a negative net margin of 10.59%. DENTSPLY SIRONA’s revenue was up .4% compared to the same quarter last year. During the same quarter in the prior year, the company earned $0.49 earnings per share. As a group, equities analysts forecast that DENTSPLY SIRONA Inc. will post 1.84 earnings per share for the current fiscal year.

DENTSPLY SIRONA Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, January 10th. Shareholders of record on Friday, December 27th will be given a dividend of $0.16 per share. This represents a $0.64 dividend on an annualized basis and a yield of 3.25%. DENTSPLY SIRONA’s payout ratio is currently -30.92%.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.